Anti-Ferritin Light Chain antibody (ab80585)

Goat polyclonal Ferritin Light Chain antibody. Validated in WB, sELISA and tested in Mouse, Rat, Human. Immunogen corresponding to synthetic peptide.


  • Product name

    Anti-Ferritin Light Chain antibody
    See all Ferritin Light Chain primary antibodies
  • Description

    Goat polyclonal to Ferritin Light Chain
  • Host species

  • Tested applications

    Suitable for: Sandwich ELISA, WBmore details
  • Species reactivity

    Reacts with: Mouse, Rat, Human
    Predicted to work with: Rabbit, Horse, Cow, Cat, Dog, Pig, Orangutan
  • Immunogen

    Synthetic peptide corresponding to Human Ferritin Light Chain aa 163-175 (C terminal) (Cysteine residue).


    Database link: NP_000137.2

  • Positive control

    • WB: Human placenta, human cerebellum, human liver, mouse brain and rat brain tissue lysates.



Our Abpromise guarantee covers the use of ab80585 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Sandwich ELISA Use a concentration of 1 - 2 µg/ml. Used as a reporter to detect recombinant FTL
WB Use a concentration of 0.3 - 1 µg/ml. Detects a band of approximately 20 kDa (predicted molecular weight: 20 kDa).


  • Function

    Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney.
  • Involvement in disease

    Defects in FTL are the cause of hereditary hyperferritinemia-cataract syndrome (HHCS) [MIM:600886]. It is an autosomal dominant disease characterized by early-onset bilateral cataract. Affected patients have elevated level of circulating ferritin. HHCS is caused by mutations in the iron responsive element (IRE) of the FTL gene.
    Defects in FTL are the cause of neurodegeneration with brain iron accumulation type 3 (NBIA3) [MIM:606159]; also known as adult-onset basal ganglia disease. It is a movement disorder with heterogeneous presentations starting in the fourth to sixth decade. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild nonprogressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels.
  • Sequence similarities

    Belongs to the ferritin family.
    Contains 1 ferritin-like diiron domain.
  • Information by UniProt
  • Database links

  • Alternative names

    • Ferritin L chain antibody
    • Ferritin L subunit antibody
    • Ferritin light chain antibody
    • Ferritin light polypeptide antibody
    • ferritin light polypeptide like 3 antibody
    • FRIL_HUMAN antibody
    • FTL antibody
    • LFTD antibody
    • NBIA 3 antibody
    • NBIA3 antibody
    see all


  • All lanes : Anti-Ferritin Light Chain antibody (ab80585) at 0.3 µg/ml

    Lane 1 : Human Brain (Cerebellum)
    Lane 2 : Liver
    Lane 3 : Human Placenta
    Lane 4 : MBR
    Lane 5 : RBR

    Lysates/proteins at 35 µg per lane.

    Predicted band size: 20 kDa

    RIPA buffer Was used for all lanes. 


ab80585 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab80585.
Please use the links above to contact us or submit feedback about this product.

For licensing inquiries, please contact

Sign up